OneMedNet Reports聽80% Reduction in Debt Enabling Focus On Growth
OneMedNet (NASDAQ:ONMD), an AI-powered AG真人官方-World Data company, reported significant financial improvements in Q2 2025. The company achieved an 80% reduction in total liabilities, decreasing from $19.7M to $6.2M, with an additional $1.9M reduction in July 2025.
Key financial highlights include $3.0M net income in Q2 2025, $3.7M raised through private placements, and holdings of 15 BTC valued at $1.6M. Operationally, OneMedNet expanded its provider network to 1,750 sites with access to 136M clinical studies, while enhancing its iRWD鈩� platform with improved AI capabilities and adding over 5 billion administrative records and claims.
OneMedNet (NASDAQ:ONMD), azienda di AG真人官方-World Data potenziata dall'IA, ha registrato notevoli miglioramenti finanziari nel secondo trimestre 2025. La societ脿 ha ottenuto una riduzione dell'80% delle passivit脿 totali, scendendo da $19,7M a $6,2M, con un'ulteriore riduzione di $1,9M a luglio 2025.
Tra i principali indicatori finanziari figurano un utile netto di $3,0M nel Q2 2025, $3,7M raccolti tramite collocamenti privati e detenzioni di 15 BTC del valore di $1,6M. Sul fronte operativo, OneMedNet ha ampliato la sua rete di fornitori a 1.750 siti con accesso a 136M di studi clinici, ha migliorato la piattaforma iRWD鈩� con funzionalit脿 IA potenziate e ha aggiunto oltre 5 miliardi di record amministrativi e di claim.
OneMedNet (NASDAQ:ONMD), compa帽铆a de AG真人官方-World Data impulsada por IA, anunci贸 mejoras financieras significativas en el segundo trimestre de 2025. La empresa logr贸 una reducci贸n del 80% en pasivos totales, pasando de $19,7M a $6,2M, con una reducci贸n adicional de $1,9M en julio de 2025.
Entre los puntos financieros clave se incluyen $3,0M de ingreso neto en el Q2 2025, $3,7M recaudados mediante colocaciones privadas y tenencias de 15 BTC valoradas en $1,6M. En operaciones, OneMedNet ampli贸 su red de proveedores a 1.750 sitios con acceso a 136M de estudios cl铆nicos, mejor贸 la plataforma iRWD鈩� con capacidades de IA ampliadas y a帽adi贸 m谩s de 5.000 millones de registros administrativos y de reclamos.
OneMedNet (NASDAQ:ONMD), AI 旮半皹鞚� AG真人官方-World Data 旮办梾鞚� 2025雲� 2攵勱赴鞐� 鞚橂 鞛堧姅 鞛 臧滌劆鞚� 氤搓碃頄堨姷雼堧嫟. 須岇偓電� 齑� 攵毂勲ゼ 80% 臧愳唽鞁滌紲 $19.7M鞐愳劀 $6.2M搿� 欷勳榾鞙茧┌, 2025雲� 7鞗旍棎 於旉皜搿� $1.9M毳� 臧愳稌頄堨姷雼堧嫟.
欤检殧 鞛 歆響滊電� 2025雲� 2攵勱赴 $3.0M 靾滌澊鞚�, 靷 氚滍枆鞚� 韱淀暣 臁半嫭頃� $3.7M, 攴鸽Μ瓿� 臧旃� $1.6M鞚� 15 BTC 氤挫湢臧 韽暔霅╇媹雼�. 鞖挫榿 旄‰┐鞐愳劀 OneMedNet鞚 瓿店笁鞛� 雱ろ姼鞗岉伂毳� 1,750臧� 靷澊韸�搿� 頇曥灔頃� 136M 瓯挫潣 鞛勳儊 鞐瓣惮鞐� 鞝戧芳頃� 靾� 鞛堦矊 頄堦碃, iRWD鈩� 頂岆灚韽检潣 AI 旮半姤鞚� 臧滌劆頄堨溂氅� 50鞏� 瓯� 鞚挫儊鞚� 頄夓爼 旮半 氚� 觳惮 雿办澊韯半ゼ 於旉皜頄堨姷雼堧嫟.
OneMedNet (NASDAQ:ONMD), soci茅t茅 de AG真人官方-World Data propuls茅e par l'IA, a annonc茅 des am茅liorations financi猫res significatives au deuxi猫me trimestre 2025. L'entreprise a r茅alis茅 une r茅duction de 80% de ses passifs totaux, passant de $19,7M 脿 $6,2M, avec une r茅duction suppl茅mentaire de $1,9M en juillet 2025.
Parmi les faits marquants figurent un r茅sultat net de $3,0M au T2 2025, $3,7M lev茅s via des placements priv茅s et une d茅tention de 15 BTC 茅valu茅e 脿 $1,6M. Sur le plan op茅rationnel, OneMedNet a 茅tendu son r茅seau de prestataires 脿 1 750 sites avec acc猫s 脿 136M d'茅tudes cliniques, a am茅lior茅 la plateforme iRWD鈩� avec des capacit茅s IA renforc茅es et a ajout茅 plus de 5 milliards d'enregistrements administratifs et de r茅clamations.
OneMedNet (NASDAQ:ONMD), ein von KI unterst眉tztes AG真人官方-World-Data-Unternehmen, verzeichnete im zweiten Quartal 2025 deutliche finanzielle Verbesserungen. Das Unternehmen erzielte eine Reduzierung der Gesamtverbindlichkeiten um 80%, von $19,7M auf $6,2M, mit einer zus盲tzlichen Verringerung von $1,9M im Juli 2025.
Wesentliche finanzielle Eckdaten sind ein Nettoergebnis von $3,0M im Q2 2025, $3,7M durch Privatplatzierungen aufgebracht und Best盲nde von 15 BTC im Wert von $1,6M. Operativ hat OneMedNet sein Anbieter-Netzwerk auf 1.750 Standorte ausgeweitet und bietet Zugang zu 136M klinischen Studien, die iRWD鈩�-Plattform mit verbesserten KI-Funktionen aufgewertet und 眉ber 5 Milliarden administrative Datens盲tze und Abrechnungen hinzugef眉gt.
- Significant debt reduction of 80%, improving balance sheet strength
- Net income of $3.0M in Q2 2025 and $1.1M YTD
- Successful private placement raising $3.7M, including $1.2M from insiders
- Strategic bitcoin holdings of 15 BTC valued at $1.6M
- Network expansion to 1,750 provider sites with access to 136M clinical studies
- Platform enhancement with 5B+ administrative records and claims data
- Significant portion of net income ($5.0M) came from debt settlements rather than operations
- Reliance on private placements for operational funding
Insights
OneMedNet's 80% debt reduction transforms balance sheet, creating financial flexibility while achieving profitability through strategic debt settlements.
OneMedNet's dramatic financial transformation stands out as the cornerstone of their Q2 2025 results. The company has executed a comprehensive liability reduction strategy, slashing total liabilities from
The financial restructuring has delivered immediate bottom-line impact, with discounted debt settlements and conversions generating
The
This financial overhaul transforms OneMedNet from a debt-burdened entity to one with significantly improved solvency metrics and operational runway, allowing management to redirect focus from balance sheet concerns to executing their RWD platform growth strategy in a rapidly evolving healthcare data market.
OneMedNet's operational expansion demonstrates substantial scaling of their iRWD鈩� platform infrastructure. The addition of 5 billion+ administrative records significantly enhances their data repository with critical health economics and social determinants information 鈥� essential elements for comprehensive healthcare analytics beyond pure clinical data.
The provider network expansion to 1,750 sites with access to 136 million clinical studies represents impressive market penetration in the fragmented healthcare data ecosystem. This expanded footprint creates a more valuable data network effect, improving both data diversity and statistical power for research applications.
The company's enhancement of AI-driven de-identification capabilities addresses a critical market need as healthcare organizations struggle with HIPAA compliance while maximizing data utility. Their focus on federated search and multi-modal data integration directly targets the healthcare industry's persistent data silos problem.
OneMedNet is strategically positioning itself at the intersection of healthcare's most valuable asset (clinical data) and the technological capabilities needed to transform that data into actionable insights. Their expanded real-world data infrastructure provides the foundation for AI applications while maintaining regulatory compliance 鈥� creating a defensible competitive position in the rapidly growing RWD market that's increasingly essential for pharmaceutical research, clinical decision support, and value-based care initiatives.
MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (鈥淥neMedNet,鈥� the 鈥淐ompany,鈥� 鈥渨e,鈥� 鈥渦s鈥� or 鈥渙ur鈥�), a leader in AI-powered AG真人官方-World Data (RWD), announced its financial results for the second quarter ended June 30, 2025, including its significantly improved balance sheet.
Second Quarter and First Half 2025 Financial Highlights
- Improved Balance Sheet: Due to the combination of debt conversions, vendor repayments, and highly discounted debt settlements, total liabilities have been reduced from
$19.7 million as of December 31, 2024, to$6.2 million as of June 30, 2025, a reduction of approximately$13.5 million . Additional discounted debt settlements in July 2025 further reduced liabilities by$1.9 million , resulting in aggregate reductions in liabilities by approximately80% since December 31, 2024.聽聽 - Net Income: The combination of discounted debt settlements and debt conversions resulted in other income of
$5.0 million in the second quarter of 2025 which contributed to overall net income of$3.0 million for the second quarter and$1.1 million of net income through June 30, 2025. - Private Placements: Successfully completed
$3.7 million in private placements of Company securities, including$1.2 million of this investment from insiders, providing capital to accelerate sales execution, expand the iRWD鈩� platform, and support customer acquisition and operations. - Bitcoin Holdings: As of June 30, 2025, the Company聽maintained a strategic digital asset position of 15聽BTC with a value of
$1.6 million .
Second Quarter Operational Highlights
- Expanded with 5 Billion+ Administrative Records and Claims, enhancing the OneMedNet Network & Platform with deep health economics and social determinants insights.
- Expanded provider network to 1,750 sites, now offering access to 136M clinical studies.
- Enhanced iRWD鈩� platform capabilities to improve AI-driven de-identification, federated search, and multi-modal data integration.
鈥淲e are focused on our strategy, and the second quarter marked an important milestone for OneMedNet, with the Company moving forward with a strong sales funnel, a scalable proven platform and an improved balance sheet. The combination of reduced debt, and strategic capital infusions enables us to focus on strategic opportunities to deliver long-term value to our customers, partners, and shareholders,鈥� says Aaron Green, CEO & President OneMedNet.
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks AG真人官方-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD鈩� platform. This isn鈥檛 just data鈥攊t鈥檚 the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet鈥檚 proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities鈥攔igorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at .
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渆xpects,鈥� 鈥渁nticipates,鈥� 鈥渃ontemplates,鈥� 鈥渆stimates,鈥� 鈥渂elieves,鈥� 鈥減lans,鈥� 鈥減rojected,鈥� 鈥減redicts,鈥� 鈥減otential,鈥� or 鈥渉opes鈥� or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin鈥檚 volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: [email protected]
SOURCE: ONEMEDNET CORPORATION
